Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

```html

The maximum days for the report to be obtained for the BRAF Mutation Analysis Test by NGS is typically 10-14 business days from receipt of the sample in the laboratory.

```

What are the prerequisites for the test BRAF Mutation Analysis Test by NGS

  • Specimen: Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides
  • Minimum Tumor Content: 20% tumor cells
  • Specimen Preparation: 10 unstained slides (5-10 microns thickness) or 1 FFPE tissue block
  • Specimen Storage: Store at room temperature
  • Rejection Criteria: Insufficient tumor content, improper fixation, specimen contamination

What are the measure values for the test BRAF Mutation Analysis Test by NGS

  • Test Name: BRAF Mutation Analysis Test by NGS
  • Measure Values:
    • Presence or absence of BRAF mutations
    • Percentage of mutation allele frequency
    • Type of BRAF mutation detected (e.g. V600E, V600K, etc.)
    • Interpretation of results (positive, negative, or inconclusive)

What does this test BRAF Mutation Analysis Test by NGS identify?

  • This test identifies mutations in the BRAF gene using Next Generation Sequencing (NGS) technology.
  • It can detect a wide range of mutations in the BRAF gene, including V600E, V600K, and other less common mutations.
  • Identification of BRAF mutations can help in the diagnosis and treatment of various cancers, such as melanoma, colorectal cancer, and thyroid cancer.
  • Results from this test can guide targeted therapy decisions and help determine prognosis for patients with BRAF-mutated cancers.

Why is this test BRAF Mutation Analysis Test by NGS taken?

The BRAF Mutation Analysis Test by NGS is taken to identify mutations in the BRAF gene. These mutations are commonly found in certain types of cancers, such as melanoma and colorectal cancer. By analyzing the BRAF gene, healthcare providers can determine the best course of treatment for patients with these types of cancers. The test uses Next-Generation Sequencing (NGS) technology to accurately detect mutations in the BRAF gene, allowing for personalized treatment plans tailored to the specific genetic makeup of each patient.

No FAQs available.

Customer Google Rating